Common diabetes drug shows promise as treatment for COVID-19 lung inflammation

Researchers identify the molecular mechanism for the anti-inflammatory activity of diabetes drug metformin and, in mouse studies, say it prevents lung inflammation in animals infected with SARS-CoV-2, the virus that causes COVID-19.